News in English
Декабрь
2024
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Новости за 12.12.2024

Miningweekly.com 

Arbitration between miner Franco-Nevada, Panama moves to next stage

Arbitration proceedings between Canadian miner Franco-Nevada and Panama over the Cobre Panama copper mine entered a new phase this week with the formation of a tribunal to hear the case, according to legal disclosures filed by the parties. Investors are awaiting Panama President Jose Raul Mulino's decision over the future of the mine, which was shut down last year due to public unrest. Cobre Panama is the flagship mine of Canadian miner First Quantum Minerals FM.TO, which is also seeking damages from Panama.

BigNewsNetwork.com (sports) 

(SP)GERMANY-DORTMUND-FOOTBALL-UEFA CHAMPIONS LEAGUE-DORTMUND VS BARCELONA

(241212) -- DORTMUND, Dec. 12, 2024 (Xinhua) -- Ramy Bensebaini (L) of Borussia Dortmund vies with Lamine Yamal of Barcelona during the UEFA Champions League match between Borussia Dortmund and FC Barcelona in Dortmund, Germany, Dec. 11, 2024. (Photo by Joachim Bywaletz/Xinhua)

FashionNetwork.com (hk) 

Stitch Fix Q1 revenue falls over 12%

Stitch Fix announced on Tuesday revenue fell 12.6% to $318.8 million in the first quarter, as active customer numbers continue to fall at the subscription-based apparel firm.

HoopsHype: Atlanta Hawks 

Jimmy Butler's agent slams Shams reporting: Stop putting my name on your complete made up bull****

That’s when Lee went to social media and unleashed a stream of posts on X aimed at Charania. “Alright listen,” Lee said to begin his response. “I gave you a pass yesterday because I was busy but if you don’t stop putting my name on your complete and utter made up bull— because you know you normally aren’t worth my time to acknowledge.”
Source: Miami Herald

Читать дальше...

Economictimes.indiatimes.com 

Cipla shares in focus after receiving CDSCO nod to launch inhalation insulin

Cipla has secured exclusive rights to distribute and market Afrezza, an inhalable insulin, in India. Developed by MannKind, Afrezza offers a non-injectable alternative for managing type 1 and type 2 diabetes. Clinical trials in India demonstrated its effectiveness in reducing HbA1c levels. Cipla aims to improve diabetes management accessibility with this innovative treatment.